| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 27 Mar 2025 | 19 Mar 2025 |
| To consider other business matters- To consider and approve the allotment of 4,80,693 fully paid-up equity shares of the Company of face value of INR 10 each, under Bonus Issue | ||
| Board Meeting | 5 Feb 2025 | 1 Feb 2025 |
| To consider bonus and other business matters including Migration of listing / trading of equity shares of the company from Emerge platform of National Stock Exchange of India Limited (NSE) to main board of National Stock Exchange of India Limited as well as on main board of BSE Ltd. Beta Drugs Limited has informed the Exchange regarding Board meeting held on February 05, 2025. (As Per NSE Announcement Dated on: 05/02/2025) | ||
| Board Meeting | 27 Nov 2024 | 22 Nov 2024 |
| BETA DRUGS LIMITED has informed the Exchange about Board Meeting to be held on 27-Nov-2024 to consider Other business. Beta Drugs Limited has informed the Exchange regarding Board meeting held on November 27, 2024. (As Per NSE Announcement Dated on: 27/11/2024) | ||
| Board Meeting | 6 Nov 2024 | 2 Nov 2024 |
| To consider and approve the financial results for the period ended September 30, 2024 Beta Drugs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2024. (As Per NSE Announcement Dated on: 06/11/2024) Beta Drugs Limited has informed the Exchange regarding Corrigendum to Notice of Extra Ordinary General Meeting to be held on November 12, 2024 (As Per NSE Announcement Dated on: 07/11/2024) | ||
| Board Meeting | 19 Oct 2024 | 16 Oct 2024 |
| To consider Fund Raising Beta Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on October 19, 2024. (As Per NSE Announcement Dated on: 19/10/2024) | ||
| Board Meeting | 31 Aug 2024 | 31 Aug 2024 |
| Beta Drugs Limited has informed the Exchange regarding Board meeting held on August 31, 2024. | ||
| Board Meeting | 8 Jul 2024 | 8 Jul 2024 |
| Beta Drugs Limited has informed the Exchange regarding Board meeting held on July 08, 2024. | ||
| Board Meeting | 14 May 2024 | 6 May 2024 |
| To consider and approve the financial results for the period ended March 31, 2024. Beta Drugs Limited has submitted to the Exchange, the financial results for the period ended March 31, 2024. (As Per BSE Announcement Dated on: 14/05/2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
